• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙拮抗剂对人血小板聚集和细胞质钙反应的抑制作用:使用水母发光蛋白和喹啉-2的研究

Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.

作者信息

Ware J A, Johnson P C, Smith M, Salzman E W

出版信息

Circ Res. 1986 Jul;59(1):39-42. doi: 10.1161/01.res.59.1.39.

DOI:10.1161/01.res.59.1.39
PMID:3089642
Abstract

Calcium antagonists inhibit platelet aggregation, but whether this action is due to inhibition of the effect of agonists on cytoplasmic ionized calcium concentration is unknown. We studied this problem by loading gel-filtered platelets with either quin2 or aequorin and stimulating them with epinephrine, arachidonate, thrombin, the calcium ionophore A23187, 1-oleoyl-2-acetyl glycerol, or adenosine diphosphate in media with or without extracellular calcium. In response to all of these agonists, aequorin indicated an increase in cytoplasmic calcium that accompanied or preceded platelet aggregation. In calcium-containing media, verapamil, nifedipine, and diltiazem inhibited these effects in a concentration-dependent fashion, except for those produced by thrombin and A23187. Removal of extracellular calcium with EGTA reduced the calcium response to arachidonate, adenosine diphosphate, and 1-oleoyl-2-acetyl glycerol, and the calcium response and aggregation were further inhibited by the calcium antagonists. In general, strong inhibition of the aequorin cytoplasmic calcium signal by approximately 100 microM concentrations of nifedipine, verapamil, and diltiazem was correlated with inhibition of platelet aggregation, but high concentrations of the inhibitors were required. Since inhibition by the calcium antagonists of the cytoplasmic calcium response and aggregation exceeded the effect of simple removal of extracellular calcium, these drugs may affect internal redistribution of calcium in human platelets.

摘要

钙拮抗剂可抑制血小板聚集,但这种作用是否归因于对激动剂作用于细胞质游离钙浓度的抑制尚不清楚。我们通过用喹2或水母发光蛋白加载凝胶过滤的血小板,并在有或没有细胞外钙的培养基中用肾上腺素、花生四烯酸、凝血酶、钙离子载体A23187、1-油酰-2-乙酰甘油或二磷酸腺苷刺激它们来研究这个问题。对所有这些激动剂的反应中,水母发光蛋白显示细胞质钙增加,伴随或先于血小板聚集。在含钙培养基中,维拉帕米、硝苯地平和地尔硫卓以浓度依赖的方式抑制这些作用,但凝血酶和A23187产生的作用除外。用乙二醇双四乙酸(EGTA)去除细胞外钙可降低对花生四烯酸、二磷酸腺苷和1-油酰-2-乙酰甘油的钙反应,并且钙拮抗剂进一步抑制钙反应和聚集。一般来说,约100微摩尔浓度的硝苯地平、维拉帕米和地尔硫卓对水母发光蛋白细胞质钙信号的强烈抑制与血小板聚集的抑制相关,但需要高浓度的抑制剂。由于钙拮抗剂对细胞质钙反应和聚集的抑制超过了简单去除细胞外钙的作用,这些药物可能会影响人血小板中钙的内部分布。

相似文献

1
Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.钙拮抗剂对人血小板聚集和细胞质钙反应的抑制作用:使用水母发光蛋白和喹啉-2的研究
Circ Res. 1986 Jul;59(1):39-42. doi: 10.1161/01.res.59.1.39.
2
Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin.常见激动剂对血小板胞质游离钙浓度的影响。用2-甲基-6-甲氧基-8-硝基喹啉(quin2)和水母发光蛋白进行测量。
J Clin Invest. 1986 Mar;77(3):878-86. doi: 10.1172/JCI112385.
3
Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.钙通道阻滞剂硝苯地平和维拉帕米对α2-肾上腺素能受体及血栓素A2诱导的人血小板聚集的不同作用。
Circulation. 1986 Apr;73(4):847-54. doi: 10.1161/01.cir.73.4.847.
4
Measurement of ionized calcium in blood platelets with the photoprotein aequorin. Comparison with Quin 2.用光蛋白水母发光蛋白测量血小板中的游离钙。与喹啉-2的比较。
J Biol Chem. 1985 Feb 25;260(4):2069-76.
5
Concurrent measurement of platelet ionized calcium concentration and aggregation: studies with the lumiaggregometer.血小板离子钙浓度与聚集的同步测量:使用发光聚集仪的研究
Thromb Res. 1985 Nov 15;40(4):435-43. doi: 10.1016/0049-3848(85)90280-4.
6
Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.钙通道阻滞剂的抗血栓形成作用:与前列环素和血栓素合酶抑制剂的协同作用。
Thromb Res. 1984 Jun 1;34(5):367-78. doi: 10.1016/0049-3848(84)90241-x.
7
In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.体外肾上腺素和胶原诱导的血小板钙动员及其被萘哌地尔、多沙唑嗪和硝苯地平抑制的情况。
Br J Clin Pharmacol. 1997 Apr;43(4):415-20. doi: 10.1046/j.1365-2125.1997.00560.x.
8
Response of aequorin-loaded platelets to activators of protein kinase C.水母发光蛋白负载的血小板对蛋白激酶C激活剂的反应。
Am J Physiol. 1989 Jan;256(1 Pt 1):C35-43. doi: 10.1152/ajpcell.1989.256.1.C35.
9
Responses to adenosine diphosphate in human platelets loaded with the fluorescent calcium indicator quin2.负载荧光钙指示剂喹啉-2的人血小板对二磷酸腺苷的反应。
J Physiol. 1985 Nov;368:131-46. doi: 10.1113/jphysiol.1985.sp015850.
10
Aequorin detects increased cytoplasmic calcium in platelets stimulated with phorbol ester or diacylglycerol.水母发光蛋白可检测到佛波酯或二酰甘油刺激的血小板中细胞质钙的增加。
Biochem Biophys Res Commun. 1985 Nov 27;133(1):98-104. doi: 10.1016/0006-291x(85)91846-7.

引用本文的文献

1
The metabolism of serotonin in neuronal cells in culture and platelets.培养的神经元细胞和血小板中血清素的代谢。
Exp Brain Res. 2007 Nov;183(3):411-6. doi: 10.1007/s00221-007-1133-7.
2
Modification of atherosclerosis by agents that do not lower cholesterol.非降胆固醇药物对动脉粥样硬化的修饰作用。
Br Heart J. 1993 Jan;69(1 Suppl):S54-62. doi: 10.1136/hrt.69.1_suppl.s54.
3
Pharmacological aspects of calcium antagonism. Short term and long term benefits.
Drugs. 1993;46 Suppl 2:40-7. doi: 10.2165/00003495-199300462-00009.
4
Synergism of platelet-aggregating agents. Role of elevation of cytoplasmic calcium.血小板聚集剂的协同作用。细胞质钙升高的作用。
J Clin Invest. 1987 Jul;80(1):267-71. doi: 10.1172/JCI113058.
5
In vivo desensitization of glycogenolysis to Ca2+-mobilizing hormones in rat liver cells.大鼠肝细胞中糖原分解对钙动员激素的体内脱敏作用。
J Clin Invest. 1988 Dec;82(6):1922-33. doi: 10.1172/JCI113811.
6
Effects of organic and inorganic Ca antagonists on rat platelet arachidonic acid metabolism in the presence of Ca2+, Sr2+ and Ba2+.
Mol Cell Biochem. 1989 Feb 21;85(2):191-6. doi: 10.1007/BF00577114.
7
Retardation of development and progression of coronary atherosclerosis: a new indication for calcium antagonists?延缓冠状动脉粥样硬化的发展和进程:钙拮抗剂的新适应证?
Eur J Clin Pharmacol. 1990;39 Suppl 1:S17-23.
8
Protective effects of calcium antagonists against ischaemia and reperfusion damage.钙拮抗剂对缺血和再灌注损伤的保护作用。
Drugs. 1991;42 Suppl 1:14-26; discussion 26-7. doi: 10.2165/00003495-199100421-00005.
9
Can the coronary atherosclerotic process be influenced by calcium antagonists?
Drugs. 1992;44 Suppl 1:123-7. doi: 10.2165/00003495-199200441-00023.